2026 COMPLETE 350 QUESTIONS AND
CORRECT DETAILED ANSWERS (VERIFIED
ANSWERS) |ALREADY GRADED A+ ANCC
FAMILY NURSING PRACTITIONER 2026
RI Diseases caused by S. pneumoniae - ANSWER//COMPS Conjunctivitis
Otitis media Meningitis Pneumonia Sinusitis Diseases caused by H. influenza
- ANSWER//COMPS Conjunctivitis Otitis media Meningitis Pneumonia
Sinusitis Common features of ABRS - ANSWER//fever and symptoms
duration of more than 10 days maxillary toothache initial symptom
improvement and then worsening of symptoms (double sickening) cacosmia
(sense of bad odor in the nose) unilateral facial pain 7 day tx is the best Tx for
ABRS in adults - ANSWER//Initial therapy: amoxicillin or amox-clav Beta-
lactam allergy: No anaphylaxis (cefdinir, cefpodoxime, cefuroxime)
anaphylaxis (levo, moxi, doxycycline) *macrolide abx (azithro, clarithro,
erythro) and TMX-SMX (Bactrim) not recommended in ABRS tx Doxycycline -
ANSWER//pregnancy risk: Cat D Resp fluroquinolones -
ANSWER//pregnancy risk: Cat C Normal hearing - ANSWER//no lateralization
AC>BC Sensorineural hearing loss - ANSWER//lateralization to good ear
(sound is heard louder in the normal ear) AC>BC Conductive hearing loss -
ANSWER//lateralization to bad ear (sound is heard louder in the bad ear)
BC>AC Allergic rhinitis - ANSWER//inflammatory, IgE mediated disease due
to genetic and environmental interactions and characterized by nasal
congestion, rhinorrhea, sneezing, intraocular and/or nasal itching Allergic
rhinitis treatment - ANSWER//1st line- avoid allergen controller - intranasal
corticosteroids (fluticasone propionate (flonase), triamcinolone)- number of
days prior to symptom relief - intranasal antihistamine (azelastine)- rapid
symptom relief Reliever therapy - 2nd gen PO antihistamine (loratadine
(clairtin), cetirizine (zyrtec) - ocular antihistamines- helpful in managing
allergic conjunctivitis signs and symptoms (olopatadine, azelastine) Sinus
present at birth - ANSWER//ethmoid and maxillary Sinus develop at 5 years of
age - ANSWER//Frontal Sinus develop at 12 years of age -
ANSWER//Sphenoid Oral Cancer - ANSWER//most cases involve squamous
cell carcinomas of the tongue and mouth floor Risk factor for SCC oral cancer
- ANSWER//More potent - longstanding HPV infection, especially HPV-16,
tobacco use, alcohol misuse Less potent - male gender, advancing age (2/3
of individuals age >55 years at time of diagnosis) Risk reduction for SCC oral
cancer - ANSWER//HPV-9 immunization avoidance/cessation of tobacco use
Presentation of SCC oral cancer - ANSWER//painless, ulcerating oral lesions,
usually presents for many months prior to presenting clinically adjacent
lymphadenopathy= immobile, nontender nodes usually >1 cm in diameter
Macular degeneration - ANSWER//thickening, sclerotic changes in retinal
basement membrane complex painless vision changes including distortion of
central vision fundoscopic exam- drusen (soft yellow deposits in the macular
region) often visible risk factors - light eye-colour, age, women, smoker Test
for macular degeneration - ANSWER//abnormal Amsler grid test presbyopia -
ANSWER//impaired vision as a result of aging close vision problems senile
,cataracts - ANSWER//lens clouding results in progressive vision dimming,
distance vision probs, close vision ok RF: smoke, poor nutrition, sun, steroid
maybe sx or lens implant can help open angle glaucoma - ANSWER//painless
gradual onset of inc intraocular pressure leading to optic atrophy loss periph if
untreated >80% of all glaucoma Screening for open angle glaucoma -
ANSWER//screening with tonometry, assessment of visual fields angle-
closure glaucoma - ANSWER//Sudden increase in intraocular pressure
Usually unilateral, acutely red, painful eye with visual change including halos
around lights Eyeball is firm when compared to other *Emergency*
Anosmia/hyposmia - ANSWER//neural degeneration resulting in loss of smell
and taste presbycusis - ANSWER//age related hearing loss loss of 8th cranial
nerve sensitivity primary prevention - ANSWER//immunizations, counseling
about safety, injury and disease prevention preventing the health problem, the
most cost-effective form of healthcare secondary prevention -
ANSWER//screening tests, such as BP check, mammo, colonoscopy
detecting disease in early asymptomatic, or preclinical state to minimize its
impact tertiary prevention - ANSWER//in established disease, adjusting
therapy to avoid further target organ damage. potentially viewed as a failure of
primary prevention minimizing negative disease induced outcomes active
immunity - ANSWER//resistance developed in response to a vaccine and
usually characterized by the presence of an antibody produced by host via
immunization onset of protection is usually within 1 month of vaccine dose
duration of protection- usually years or lifelong passive immunity -
ANSWER//Immunity conferred by transferring antibodies from an individual
who is immune to a pathogen to another individual. onset of protection-
usually within hours of dose duration of protection- usually time-limits, usually
6-9 months available for limited number of infectious disease including
varicella, hep A or B, tetanus, rabies, others Urticaria - ANSWER//hives Hep
A - ANSWER//contaminated food or water Live Vaccines - ANSWER//MMR,
Varicella, intranasal influenza- not given during pregnancy Rotavirus (oral)-
not given with SCID harmless virus shed from stool in first weeks post
vaccine- standard diaper hygiene and handwashing MMR - ANSWER//dose
1- 12 months dose 2- 4-6 years Varicella - ANSWER//dose 1- 12 months dose
2- 4-6 years Rotavirus - ANSWER//max age for 1st dose- 14 weeks 6 days
max age for last dose- 8 months Stages of change -
ANSWER//precontemplation, contemplation, preparation, action, maintenance
5 A's of smoking cessation - ANSWER//1. Ask 2. Advise 3. Assess 4. Assist 5.
Arrange leading cause of death in 10-44 - ANSWER//unintentional injury
leading cause of death in 45-64 - ANSWER//cancer Hemoglobin/Hematocrit
(H&H) ratio - ANSWER//1:3 RBC size (MCV) - ANSWER//microcytic- MCV
<80 normocytic- MCV 80-96 macrocytic- MCV >96 MCHC -
ANSWER//normochromic- MCHC 31-37 hypochromic- <31 RDW -
ANSWER//11.5-14.5% Normal reticulocyte count - ANSWER//1-2%
normocytic normochromic anemia with NL RDW - ANSWER//anemia of
chronic disease chronic kidney disease acute blood loss Next step: dictated
by suspected underlying cause microcytic, hypochromic, elevated RDW -
ANSWER//Iron deficiency plumbism (lead toxicity) Next step: ferritin for
estimate iron stores add lead testing in younger children microcytic,
hypochromic anemia, NL RDW - ANSWER//thalassemia trait alpa
thalassemia minor - ANSWER//A, A, A asian, african ancestry beta
, thalassemia minor - ANSWER//B, A, M, M, E african, mediterranean, middle
eastern ancestry next step: hemoglobin electrophoresis for evaluation of
hemoglobin variant macrocytic normochromic anemia with elevated RDW -
ANSWER//vitamin B12 deficiency, especially pernicious anemia folate
deficiency anemia next step: serum vitamin B12 and RBC folate drug induced
macrocystosis usually without anemia - ANSWER//alcohol (Excess)
antiepileptic drugs (cabamazepine, phenytoin, methotrexate) most common:
excessive alcohol >5 drink per day in male, >3 drinks per day in female next
step: usually not needed Hemic murmur - ANSWER//shows up in absence of
cardiac pathology but contact more than normal high fever, profound
dehydration, anemia is bad, thyroid toxicosis happens in 3rd trimester of
preggo sometimes WBC - ANSWER//Nobody Likes My Educational
Background neutrophils- 60% (bacteria) lymphocyte- 30% (virus) monocyte-
6% (debris) eosinophil- 3% (allergens, parasites (worms, wheezes, weird
diseases) basophil- 1% (anaphylaxis) Level of evidence ranking -
ANSWER//meta-analysis or systematic review
(cochrane/medline/cinahl/pubmed) RCTs experimental studies (control group,
intervention group) cohort/case control studies retrospective chart reviews
expert/specialty society opinions basal cell carcinoma - ANSWER//skin lesion
has pearly or waxlike appearance with telangiectasia risk factors: light-colored
skin actinic keratosis - ANSWER//a precancerous skin growth that occurs on
sun-damaged skin gold standard for skin cancer - ANSWER//skin biopsy
Benzodiazepines - ANSWER//treat anxiety or insomnia Mood stabilizers -
ANSWER//lithium treat bipolar disorder first line for depression -
ANSWER//SSRI SSRI Drugs - ANSWER//Citalopram (Celexa) Escitalopram
(Lexapro) Fluoxetine (Prozac) Paroxetine (Paxil) Sertraline (Zoloft) CAGE
questionnaire - ANSWER//cut down, annoyed, guilty, eye opener Thiazides -
ANSWER//contraindicated in gout what to monitor in ACE and ARB -
ANSWER//serum potassium and creatinine levels goal of INR in pt with Afib -
ANSWER//2-3 goal of INR with prosthetic heart valves - ANSWER//2.5-3.5
herb feverfew - ANSWER//used for migraine, irregular menstrual periods,
tinnitus pharmokinectics: age-related changes - ANSWER//increase in fat-to-
water ration decrease in albumin and plasma proteins decrease in liver blood
flow and size decrease in some CYP450 enzyme pathways (decreased drug
clearance) decrease in GFR Drug-drug interactions drugs -
ANSWER//macrolides (erythro, clarithro, telithro) antifungals (ketoconozole,
flucanazole, itraconazole) cimetidine citalopram grapefruit juice protease
inhibitors (saquinavir, indinavir, nelfinavir) BEERS criteria - ANSWER//drugs
avoided in elderly antipsychotics (quetiapine, clozapine, pimavanserin- use
with caution) rivaroxaban and dabigatran (higher bleeding risk than warfarin)
tramadol (risk of hyponatremia from SIAHS) opioids Digoxin -
ANSWER//narrow therapeutic range (0.5-2.0) signs and symptoms of
overdose: GI symptoms (nausea, vomiting), hypokalemia, hypercalcemia,
confusion, visual changes (yellowish-green-tinged color vision),
bradydysrhythmias, tachydysrhythmias Side effects of levothyroxine -
ANSWER//palpitations, Tachycardia, restlessness, diarrhea, weight loss,
decreased bone density, heat intolerance, and insomnia. organ systems
affected by NSAIDs - ANSWER//cardiovascular hematopoietic integumentary
(SJS) TSH levels - ANSWER//0.4-4.0 Paroxetine (Paxil) - ANSWER//SSRI
cause erectile dysfunction Escitalopram (Lexapro) - ANSWER//SSRI cause